Department of Gastroenterology, Shenzhen People's Hospital, Shenzhen 518020, Guangdong Province, China.
Department of Pathology, Shenzhen People's Hospital, Shenzhen 518020, Guangdong Province, China.
World J Gastroenterol. 2024 Aug 28;30(32):3748-3754. doi: 10.3748/wjg.v30.i32.3748.
The majority of esophageal subepithelial lesions originating from the muscularis propria (SEL-MPs) are benign in nature, although a subset may exhibit malignant characteristics. Conventional endoscopic resection techniques are time-consuming and lack efficacy for small SEL-MPs.
To evaluate the efficacy and safety of ligation-assisted endoscopic submucosal resection (ESMR-L) following unroofing technique for small esophageal SEL-MPs.
From January 2021 to September 2023, 17 patients diagnosed with esophageal SEL-MPs underwent ESMR-L following unroofing technique at the endoscopy center of Shenzhen People's Hospital. Details of clinicopathological characteristics and clinical outcomes were collected and analyzed.
The mean age of the patients was 50.12 ± 12.65 years. The mean size of the tumors was 7.47 ± 2.83 mm and all cases achieved resection successfully. The average operation time was 12.2 minutes without any complications. Histopathology identified 2 Lesions (11.8%) as gastrointestinal stromal tumors at very low risk, 12 Lesions (70.6%) as leiomyoma and 3 Lesions (17.6%) as smooth muscle proliferation. No recurrence was found during the mean follow-up duration of 14.18 ± 9.62 months.
ESMR-L following roofing technique is an effective and safe technique for management of esophageal SEL-MPs smaller than 20 mm, but it cannot ensure resection and may require further treatment.
起源于固有肌层的大多数食管黏膜下病变(SEL-MPs)本质上是良性的,尽管有一部分可能表现出恶性特征。传统的内镜下切除技术耗时且对小的 SEL-MPs 疗效不佳。
评估经开窗技术辅助套扎的内镜黏膜下剥离术(ESMR-L)治疗小的食管 SEL-MPs 的疗效和安全性。
2021 年 1 月至 2023 年 9 月,深圳市人民医院内镜中心对 17 例食管 SEL-MPs 患者采用经开窗技术行 ESMR-L 治疗。收集并分析了患者的临床病理特征和临床转归。
患者的平均年龄为 50.12 ± 12.65 岁。肿瘤平均大小为 7.47 ± 2.83mm,所有病例均成功切除。平均手术时间为 12.2 分钟,无任何并发症。组织病理学检查发现 2 个病变(11.8%)为极低风险的胃肠道间质瘤,12 个病变(70.6%)为平滑肌瘤,3 个病变(17.6%)为平滑肌增生。平均随访 14.18 ± 9.62 个月,未发现复发。
经开窗技术辅助套扎的 ESMR-L 是一种治疗直径小于 20mm 的食管 SEL-MPs 的有效且安全的技术,但不能保证完全切除,可能需要进一步治疗。